Evidence map›Paper›PMID 38988571›Full record

ArticleHeliyon2024

Cranial hypertrophic pachymeningitis with myelodysplastic syndrome.

Shohei Kikuchi, Tomohiro Hayashi, Honoka Nitta, Yusuke Kamihara, Akinori Wada, Tomoki Minemura, Yoshimi Nabe, Jun Murakami, Yuji Nakatsuji, Tsutomu Sato

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Shohei KikuchiDepartment of Hematology, Toyama University Hospital, Toyama, Japan.
Tomohiro HayashiDepartment of Neurology, Toyama University Hospital, Toyama, Japan.
Honoka NittaDepartment of Clinical Laboratory and Blood Center, Toyama University Hospital, Toyama, Japan.
Yusuke KamiharaDepartment of Hematology, Toyama University Hospital, Toyama, Japan.
Akinori WadaDepartment of Hematology, Toyama University Hospital, Toyama, Japan.
Tomoki MinemuraDepartment of Hematology, Toyama University Hospital, Toyama, Japan.
Yoshimi NabeDepartment of Hematology, Toyama University Hospital, Toyama, Japan.
Jun MurakamiDivision of Transfusion Medicine and Cell Therapy, Toyama University Hospital, Toyama, Japan.
Yuji NakatsujiDepartment of Neurology, Toyama University Hospital, Toyama, Japan.
Tsutomu SatoDepartment of Hematology, Toyama University Hospital, Toyama, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypertrophic pachymeningitis (HP) is a rare inflammatory disease characterized by thickening of the dura mater. HP develops with several inflammatory diseases. Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis and IgG4 related disease are reported as 2 major causes. With hematologic diseases, only 3 cases have been reported. We report the case of myelodysplastic syndrome (MDS) developing HP. Our case provides a thought-provoking hypothesis regarding the potential relationship between MDS and HP.

Indexed as

Hypertrophic pachymeningitisMyelodysplastic syndromeSteroids therapy

Identifiers

PMID38988571
PMCPMC11233996

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.